1.
Malone ER, Sim H-W, Stundzia A, Pierre S, Metser U, O’Malley M, Sacher AG, Sridhar SS, Hansen AR. Predictive radiomics signature for treatment response to nivolumab in patients with advanced renal cell carcinoma. CUAJ [Internet]. 2021 Sep. 24 [cited 2022 May 22];16(2):E94-101. Available from: https://cuaj.ca/index.php/journal/article/view/7467